Our drug R&D is supported by scientific research published by the Akero team, our collaborators, and by external experts.
Jul 2018 | FROM EXTERNAL EXPERTS
A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling
Jun 2018 | FROM EXTERNAL EXPERTS
Recent advances in understanding and managing non-alcoholic fatty liver disease
Jan 2018 | From External Experts
Structures of β-klotho reveal a ‘zip code’-like mechanism for endocrine FGF signalling
Jan 2018 | FROM EXTERNAL EXPERTS
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Apr 2017 | FROM EXTERNAL EXPERTS
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists

